Literature DB >> 6795075

Haemostatic changes in diabetic coma.

R C Paton.   

Abstract

Diabetic coma is frequently associated with thromboembolic complications. A prospective study was undertaken of the haemostatic changes occurring in 15 patients (12 with ketoacidosis, three with the hyperosmolar syndrome) during diabetic coma. When compared with the results after stabilization of the diabetes, ketoacidosis was associated with significantly higher levels of factor VIII coagulant activity, factor VIII-related antigen and fibrin degradation products, a shorter partial thromboplastin time and reduced concentrations of antithrombin III. These results suggest that in uncomplicated ketoacidosis, haematological changes occur which may reflect vascular endothelial damage and intravascular fibrin deposition. Out of three deaths, two patients (both with the hyperosmolar syndrome) had evidence of disseminated intravascular coagulation. To reduce further the mortality and morbidity from diabetic coma, controlled clinical trials of anticoagulant and antiplatelet drugs may be indicated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795075     DOI: 10.1007/BF00252650

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

Review 2.  Blood coagulation in pathological thrombus formation and the detection in blood of a thrombotic tendency.

Authors:  J A Davies; G P McNicol
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

Review 3.  Normal and abnormal haemostasis.

Authors:  J F Mustard; M A Packham
Journal:  Br Med Bull       Date:  1977-09       Impact factor: 4.291

Review 4.  Disseminated intravascular coagulation (DIC): an approach.

Authors:  R W Colman; S J Robboy; J D Minna
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

Review 5.  Platelet function in diabetes mellitus.

Authors:  J A Colwell; P V Halushka
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

6.  Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.

Authors:  J Gonzalez; J A Colwell; K E Sarji; R M Nair; J Sagel
Journal:  Thromb Res       Date:  1980 Jan 1-15       Impact factor: 3.944

7.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.

Authors:  B Bennett; O D Ratnoff
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.

Authors:  C M Ogston; D Ogston
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

10.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20
View more
  11 in total

1.  Diabetic ketoacidosis: current views on pathogenesis and treatment.

Authors:  U Keller
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

2.  Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

Authors:  M Greaves; C Pickering; G Knight; A J Boulton; J Ball; J D Ward; F E Preston
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 3.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

4.  Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

Authors:  R C Paton; P B Kernoff; J K Wales; G P McNicol
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-17

5.  No rationale for antiplatelet drug treatment in diabetic ketoacidosis.

Authors:  H U Janka; H Mehnert
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

6.  Antiplatelet/anticoagulant drug therapy in severely uncontrolled diabetes mellitus.

Authors:  P Carroll; R Matz
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

Review 7.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Authors:  Jean-Louis Chiasson; Nahla Aris-Jilwan; Raphaël Bélanger; Sylvie Bertrand; Hugues Beauregard; Jean-Marie Ekoé; Hélène Fournier; Jana Havrankova
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

8.  Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S H Ibbotson; D Walmsley; J A Davies; P J Grant
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

9.  Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man.

Authors:  G Mauricio-Leguizamo; L Heinemann; R E Scharf; M Berger
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

10.  Diabetic ketoacidosis-associated stroke in children and youth.

Authors:  Jennifer Ruth Foster; Gavin Morrison; Douglas D Fraser
Journal:  Stroke Res Treat       Date:  2011-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.